Transcription of Herceptin® (trastuzumab), Kadcyla®(ado …
{{id}} {{{paragraph}}}
/ / / / / / / / / / Page 1 of 3 Herceptin (trastuzumab), Kadcyla (ado-trastuzumab) and Perjeta ( pertuzumab ) injectable medication precertification request Aetna precertification Notification 503 Sunport Lane, Orlando, FL 32809 Phone: 1-866-503-0857 FAX: 1-888-267-3277 For Medicare Advantage Part B: FAX: 1-844-268-7263 (All fields must be completed and legible for precertification Review.)
Positive Fluorescent in situ hybridization (FISH) HER2 gene copy of greater than 6 signals/nucleus / / / / / / / / / / Page 1 of 3 : Herceptin® (trastuzumab), Kadcyla® (ado-trastuzumab) and Perjeta® (pertuzumab) Injectable Medication Precertification Request
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
And Reimbursement Considerations for Specialty Drugs, And Reimbursement Considerations for Specialty, Specialty Pharmacy in Community Pharmacy, Specialty, Injectable, Botulinum Toxins Injectable Medication, Botulinum Toxins Injectable Medication Precertification Request, Annual Charge Master Update, Drugs, The Connecticut Opioid REsponse Initiative, Instructions for SPA Paper Application, Vaccine Production Strategies: Ensuring Alignment, Vaccine Production Strategies: Ensuring Alignment and Sustainability